-
DE
Tau proteins stabilise the neuronal cell framework. In Alzheimer's disease, pathological tau changes lead to cell degradation. Find out all about function, diagnostics and current therapeutic approaches.
Tau proteins stabilise the neuronal cell framework. In Alzheimer's disease, pathological tau changes lead to cell degradation. Find out all about function, diagnostics and current therapeutic approaches.
Tau proteins are the body's own structure-stabilising proteins that occur primarily in nerve cells of the central nervous system. Their main function lies in the stabilisation of microtubules, i.e. the "transport tracks" within nerve cells that are crucial for cell transport and the maintenance of cell structure.
In a healthy brain, tau ensures that the microtubules remain stable and the nerve cells can work efficiently. It acts like a "scaffold protein" that ensures that nutrients, neurotransmitter vesicles and other cell components are transported in the right direction.
In neurodegenerative diseases, in particular Alzheimer's, there is defective phosphorylation of the tau protein:
The result: axonal transport breaks down, nerve cells degenerate and die. In the advanced stage of Alzheimer's disease, the amount of tau deposits correlates more strongly with cognitive decline than amyloid plaques - which is why tau is now considered a central target for diagnostics and therapy.
Tau proteins can be detected using various methods:
In addition to Alzheimer's disease, tau is also pathologically altered in other neurodegenerative diseases - these are referred to as tauopathies, e.g.:
Tau is the focus of modern Alzheimer's research:
Tau proteins are essential for neuronal stability and communication. Their dysfunction is a central mechanism of Alzheimer's disease and other dementias. In the future, tau-based diagnostics and therapy could play an important role in individualised dementia treatment.
Literature references: